Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413699
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2006-12-18
Brief Title:
Long-Term Effectiveness And Safety Of CP-690550 For The Treatment Of Rheumatoid Arthritis
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Long-term Open-label Follow-up Study Of Tofacitinib Cp-690550 For Treatment Of Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the long-term effectiveness and safety of CP-690550 for the treatment of rheumatoid arthritis Subjects are eligible for this study only after participating in another qualifying study of CP-690550
A sub-study will be conducted within the A3921024 study this study will evaluate the immune response to pneumococcal and influenza vaccines in patients receiving CP-690550
A sub-study will be conducted within the A3921024 study this study will evaluate the immune response to pneumococcal and influenza vaccines in patients receiving CP-690550
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-005035-19 | EUDRACT_NUMBER | None | None |